Berges O, Belkacemi Y, Giraud P
Service d'Oncologie-Radiothérapie, Hôpital Européen Georges-Pompidou, Université Paris Descartes, 20 rue Leblanc, 75015 Paris, France.
Cancer Radiother. 2010 Jul;14(4-5):307-11. doi: 10.1016/j.canrad.2010.03.005. Epub 2010 Jul 1.
The thyroid is the most developed endocrine gland of the body. Due to its anatomical location, it may be exposed to ionizing radiation in external radiotherapy involving head and neck. This review aims to describe the thyroid radiation disorders, probably under-reported in the literature, their risk factors and follow-up procedures. The functional changes after external beam radiation consists mainly of late effects occurring beyond 6 months, and are represented by the clinical and subclinical hypothyroidism. Its incidence is approximately 20 to 30% and it can occur after more than 25 years after radiation exposure. Hyperthyroidism and auto-immune manifestations have been described in a lesser proportion. The morphological changes consist of benign lesions, primarily adenomas, and malignant lesions, the most feared and which incidence is 0.35%. The onset of hypothyroidism depends of the total dose delivered to the gland, and the irradiated. Modern techniques of conformal radiotherapy with modulated intensity could improve the preservation of the thyroid, at the expense of the increase in low doses and the theoretical risk of secondary cancers.
甲状腺是人体最发达的内分泌腺。由于其解剖位置,在涉及头颈部的外照射放疗中,它可能会受到电离辐射。本综述旨在描述甲状腺辐射紊乱(可能在文献中报道不足)、其风险因素及随访程序。外照射后的功能变化主要由6个月后出现的晚期效应组成,表现为临床和亚临床甲状腺功能减退。其发生率约为20%至30%,可在辐射暴露25年以上后发生。甲状腺功能亢进和自身免疫表现的描述比例较低。形态学变化包括良性病变,主要是腺瘤,以及恶性病变,其中最令人担忧的是恶性病变,其发生率为0.35%。甲状腺功能减退的发生取决于给予腺体的总剂量以及受照射情况。现代调强适形放疗技术可以改善甲状腺的保护,但代价是低剂量增加以及继发癌症的理论风险增加。